Imvax Imvax is a biotechnology company that develops vaccines and immunotherapy strategies for the treatment of malignant gliomas and other cancers. | ||
Founding Date | Founding Date 1997 | Founding Date 2015 |
Type | Type Subsidiary | Type Private |
Tags | ||
Locations | Locations London, GB HQ Oxford, GB | Locations Philadelphia, US HQ |
Employees | Employees 6 | Employees 2723% decrease |
Imvax is a biotechnology company that develops vaccines and immunotherapy strategies for the treatment of malignant gliomas and other cancers.
View company